Amare Cor Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.75 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 20.83%
- Profit Growth 130.54%
- Ebitda 91.37%
- Net Worth 15.23%
- Total Assets -6.81%
About Amare Cor Pharmaceuticals
Amare Cor Pharmaceuticals Private Limited (ACPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 May 2016 (Eight years and nine months 1 days old ). Its registered office is in Ranchi, Jharkhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹1.00 M.
Meghashini, Deepika Kumari, and Arsh Ranjan serve as directors at the Company.
Company Details
-
Location
Ranchi, Jharkhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909JH2016PTC008735
-
Company No.
008735
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 May 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Amare Cor Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meghashini
|
Director | 10-May-2016 | Current |
|
Deepika Kumari
|
Director | 10-May-2016 | Current |
|
Arsh Ranjan
|
Director | 15-May-2019 | Current |
Financial Performance of Amare Cor Pharmaceuticals.
Amare Cor Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.83% increase. The company also saw a substantial improvement in profitability, with a 130.54% increase in profit. The company's net worth Soared by an impressive increase of 15.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amare Cor Pharmaceuticals?
In 2023, Amare Cor Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Adlife Biochem (Abc) Diagnostics LlpArsh Ranjan is a mutual person
-
Medvyom Pharma Private Limited
Arsh Ranjan is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2019 | Indian Bank | ₹1.00 M | Open |
How Many Employees Work at Amare Cor Pharmaceuticals?
Amare Cor Pharmaceuticals has a workforce of 3 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amare Cor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amare Cor Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.